GenomeUp vs WhaleAlerts: Revenue, Funding & Team Size Compared
GenomeUp generates $229.9K in revenue; WhaleAlerts generates $235.7K. WhaleAlerts and GenomeUp are close to the same size by revenue. The table below compares GenomeUp and WhaleAlerts on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $229.9K | $235.7K |
| Valuation | Not disclosed | $1.4M |
| Funding raised | $280.5K | Not disclosed |
| Team size | 31 | 4 |
| Founded | 2017 | 2013 |
| HQ | Rome, Italy | San Francisco, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
GenomeUp at a glance
GenomeUp generates $229.9K in revenue with 31 employees, headquartered in Rome, Italy.
- Revenue
- $229.9K
- Funding
- $280.5K
- Team size
- 31
- Founded
- 2017
GenomeUp is an AI platform for enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24 hours.
WhaleAlerts at a glance
WhaleAlerts generates $235.7K in revenue with 4 employees, headquartered in San Francisco, United States.
- Revenue
- $235.7K
- Valuation
- $1.4M
- Team size
- 4
- Founded
- 2013
WhaleAlerts develops enterprise SaaS sales acceleration tools on top of a user data platform
Other GenomeUp alternatives
GenomeUp competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
GenomeUp vs WhaleAlerts: frequently asked questions
Is GenomeUp or WhaleAlerts bigger?
WhaleAlerts is the bigger company by revenue, at $235.7K against $229.9K for GenomeUp.
How much revenue does GenomeUp make?
GenomeUp generates $229.9K in annual revenue with a team of 31.
How much revenue does WhaleAlerts make?
WhaleAlerts generates $235.7K in annual revenue with a team of 4.
How much funding has GenomeUp raised?
GenomeUp has raised $280.5K in total funding since it was founded in 2017.